Found: 14
Select item for more details and to access through your institution.
Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 2, p. 1, doi. 10.1002/cti2.1246
- By:
- Publication type:
- Article
Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy.
- Published in:
- Nature Communications, 2016, v. 7, n. 9, p. 12878, doi. 10.1038/ncomms12878
- By:
- Publication type:
- Article
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00872-4
- By:
- Publication type:
- Article
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24562-2
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 4, p. 286, doi. 10.1007/s11899-019-00523-x
- By:
- Publication type:
- Article
IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 8, p. 3383, doi. 10.1172/JCI68395
- By:
- Publication type:
- Article
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
- Published in:
- Nature Immunology, 2001, v. 2, n. 3, p. 261, doi. 10.1038/85330
- By:
- Publication type:
- Article
CD40 regulates human dendritic cell-derived IL-7 production that, in turn, contributes to CD8<sup>+</sup> T-cell antigen-specific expansion.
- Published in:
- Immunology & Cell Biology, 2009, v. 87, n. 2, p. 167, doi. 10.1038/icb.2008.80
- By:
- Publication type:
- Article
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens.
- Published in:
- Genome Medicine, 2016, v. 8, p. 1, doi. 10.1186/s13073-016-0264-5
- By:
- Publication type:
- Article
Heating up cancer vaccines.
- Published in:
- Science Immunology, 2017, v. 2, n. 17, p. 1, doi. 10.1126/sciimmunol.aap9419
- By:
- Publication type:
- Article
PD-1:PD-L inhibitory pathway affects both CD4.
- Published in:
- European Journal of Immunology, 2002, v. 32, n. 3, p. 634, doi. 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
- By:
- Publication type:
- Article
β.
- Published in:
- European Journal of Immunology, 1995, v. 25, n. 11, p. 3011, doi. 10.1002/eji.1830251104
- By:
- Publication type:
- Article
Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface.
- Published in:
- European Journal of Immunology, 1994, v. 24, n. 6, p. 1285, doi. 10.1002/eji.1830240607
- By:
- Publication type:
- Article
Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines.
- Published in:
- Cancers, 2011, v. 3, n. 4, p. 4191, doi. 10.3390/cancers3044191
- By:
- Publication type:
- Article